Study Purpose: This research is for advanced Parkinson's Disease patients to test a new treatment, called NouvNeu001. The study will check if the treatment is safe and how well it works.
Study Process: Patients will receive an injection of cells into their brain using a special surgery called stereotactic neurosurgery. After the surgery, they will take medicine to prevent the body's defense system from rejecting the new cells for 24 to 36 weeks.
Eligibility: Participants must be between 30 and 75 years old, have had Parkinson's Disease for 4 to 20 years, and meet specific health criteria. They cannot have certain other medical conditions or be in other clinical trials recently.
- Participants will need to attend several doctor visits and have tests like MRI scans.
- They must agree not to have other brain surgeries or join other studies during and after this trial.
- After the surgery, participants should use birth control as per local rules for a year.
How understandable was the trial content above?
Hard to understand
Easy to understand